Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study

Iben F Sorgenfrei, Kathrine Norrild, Per Bo Larsen, Jakob Stensballe, Doris Ostergaard, Martine E Prins, Jørgen Viby-Mogensen

    256 Citations (Scopus)

    Abstract

    Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced block.
    Original languageEnglish
    JournalAnesthesiology
    Volume104
    Issue number4
    Pages (from-to)667-74
    Number of pages8
    ISSN0003-3022
    Publication statusPublished - 1 Apr 2006

    Fingerprint

    Dive into the research topics of 'Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study'. Together they form a unique fingerprint.

    Cite this